BeStock  

MiniMed Group MMED

US equityMarket cap rank #2130Medical Instruments & Supplies
$16.01 −$0.25 (-1.54%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $16.21 +1.25%
Open$16.08
Prev close$16.26
Day range$15.92 – $16.79
Volume4.58M
Market cap$4.50B
P/E (TTM)–
Dividend yield–

Price chart

Daily bars for up to one year, weekly bars for the 5-year view. Averages are 50/200 trading days (10/40 weeks on the 5-year view). Triangles mark past earnings reports, colored by that day’s move; ticks mark ex-dividend dates — hover either for the date. Volume is the shaded bars under the price; switch on RSI or MACD above for a full-history oscillator panel, or Bollinger Bands for the same 20-day/2-standard-deviation channel used in the Technical signals table.

MMED at a glance

Shares of MiniMed Group are down 1.54% at $16.01. The company is worth $4.50B, number 2130 out of 3753 on our list.

The 52-week range is $10.65 to $24.43. Today's price is about 39% of the way from the low to the high.

For the quarter ended Jul 2026 it reported $843.00M in revenue, up 16.6% from a year earlier, with $0.00 of net profit (a -9.7% margin).

13 analysts follow the stock and the average call is "buy". The mean target, $26.42, sits 65.0% over where the stock trades.

This summary is put together from the numbers on the page and updates when they do. It describes the data; it is not a forecast or a recommendation.

Key statistics

Bid / Ask$16.15 / $17.00
Average price today$16.15
Volume4.58MAvg (90d) 6.38M
Turnover$73.94M
Turnover rate16.08%of shares outstanding
Volume ratio0.69vs. recent average pace
Day amplitude5.35%
Market cap$4.50B
Float market cap$455.75M
Shares outstanding28.47M
EPS (TTM)-$1.30
P/B1.24
Book value / share$12.87
Net profit (TTM)-$365.75M
Net assets$3.62B
30-day volatility64.9%annualized
Avg daily range (ATR)6.56%of price, 14 days
Max drawdown (1y)-41.6%-32.8% from 1y peak

Quote as of Nov 20, 2026 8:10 pm ET. Prices can lag the live tape. This is background information, not a recommendation.

BeStock Grade

C
BeStock Grade

Composite of 3 factors below, ranked against the 3734 U.S. stocks BeStock covers.

C
Valuation

Cheaper than usual on its own 5-year P/E history scores higher.

D
Momentum

Trading closer to its 52-week high than most peers scores higher.

B
Wall Street

13 analysts, consensus Buy.

How this is scored: each factor above is a 0–100 percentile rank against every other stock BeStock covers (or, for Wall Street, against the five-point Strong Buy–Sell scale). The overall grade is the plain average of whichever factors apply to this stock — no factor is weighted more than another. That average maps to a letter: A ≥ 85, B ≥ 70, C ≥ 50, D ≥ 30, otherwise F. Recomputed from the data on this page as prices and filings update — it describes where a stock ranks today, not a forecast, and not a BeStock recommendation to buy or sell.

Six-factor research snapshot

Overall percentile: 41.1 · 2026-11-22 08:27 UTC. Higher values indicate a stronger relative ranking.

FactorPercentile
Valuation29.5
Growth—
Profitability21.8
Momentum49.9
Financial health84.5
Analyst view77.2

Price forecast

What Wall Street analysts and Morningstar's fair-value model expect for the stock

Analyst price target (avg)$26.42+65.0% vs. current price
Consensus ratingBuy13 analysts covering
Morningstar fair value$17.37Price is below fair value

Wall Street’s average 12-month target is $26.42, 65.0% above today’s price, with a consensus rating of Buy. Morningstar’s fair value model puts the stock at $17.37, so shares trade 7.8% below that estimate. On earnings multiple, it sits in the 34th percentile of its own five-year valuation range (cheaper than usual).

Figures are Wall Street analyst consensus and Morningstar’s independent fair-value model, sourced as noted above.

Performance

Price return over each window, from adjusted daily and weekly closes

1 day
-1.5%
1 week
-11.0%
1 month
-12.5%
3 months
-19.7%
6 months
+34.9%
Day range
$15.92$16.79
52-week range
$10.65$24.43

Technical signals

Full technicals →
Trend readStrong downtrend

0 bullish · 4 bearish of 5 signals

IndicatorValueSignal
Price vs 20-day average-11.4%Bearish
Price vs 50-day average-15.9%Bearish
RSI (14)36.6Bearish
MACD (12,26,9)-0.59Bearish
Bollinger band position-2%Neutral

Standard indicator readings worked out from daily closes. They describe how the price has behaved, not where it is going.

How MMED ranks on BeStock

Market value#2123 of 3734
Closeness to 52-week high#2416 of 3724
Dollar volume today#1159 of 3734

Ranks are among the 3,734 or so U.S.-listed stocks BeStock covers, recalculated whenever prices refresh. A tile is left out when the measure does not apply, such as yield for a stock that pays no dividend.

MMED is not currently one of the 10 holdings in BeStock Momentum, our rules-based momentum strategy.

Since 2020-12-28, the strategy has returned 401.7% (183.6% for the equal-weight average of BeStock’s coverage over the same stretch). Holdings can change any trading day, not just on a fixed schedule. Backtested performance, updated daily — not a guarantee of future results, and not a BeStock recommendation.

Strategy Backtest

Pick a strategy above and run the backtest to see its simulated performance on MMED.

Rule-based technical strategies computed from this stock’s own price history only. Signals use only data available through the prior trading day (no look-ahead), and trading costs, slippage and taxes aren’t modeled. A backtested rule performing well in the past is not a guarantee of future results — this is an educational illustration, not investment advice.

Community Sentiment on MMED

No votes yet — be the first to weigh in.

Reader sentiment, not investment advice. One vote per visitor; click again to change it.

MMED stock: common questions

How is MiniMed Group stock doing today?

$16.01 is the latest print for MMED, a move of -1.54% against yesterday's close of $16.26. Today's low and high so far: $15.92 and $16.79.

How big is MiniMed Group?

Equity value comes to $4.50B at the current price. By that measure it is number 2130 of the 3753 names in our coverage.

Where does MMED sit in its 52-week range?

The year's floor is $10.65 and the ceiling $24.43. Shares are 34.5% away from that ceiling.

Does MMED send cash back through a dividend?

Our data shows no dividend paid by MiniMed Group over the trailing twelve months.

Do Wall Street analysts like MMED?

Of 13 analysts, 85% say buy, 15% hold and 0% sell. Price targets average $26.42, with the most cautious at $20.00 and the most optimistic at $30.00.

BeStock publishes market data and analysis for information only. Nothing here is investment advice or a solicitation to buy or sell any security, and none of it is tailored to your financial situation, goals, or risk tolerance. Quotes may be delayed and figures can contain errors; check primary sources before you trade. How we source and calculate these pages.

Discussion

No comments yet — be the first to weigh in on MMED.

Sign in to join the discussion.

Scroll to Top